In May, we launched a joint project between a research team based at Lifehouse and the Glycomics Institute at Griffith University in Queensland. Patients at Lifehouse are providing tissue samples that will be sent to the Glycomics Institute.
Glycomics is the study of the carbohydrates that appear on the surface of both healthy and diseased cells. These so-called “sugar” signatures play a pivotal role in the life of a cell, not the least being their part in determining cancer growth and development. We will identify the link between these carbohydrate (“sugar”) patterns and cancer progression in order to develop new biomarkers of outcome and new drugs aimed at these molecules.
This collaboration has attracted $2.5 million in philanthropic funding.